Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 15;12(4):e058317.
doi: 10.1136/bmjopen-2021-058317.

Why 'one size fits all' is not enough when designing COVID-19 immunity certificates for domestic use: a UK-wide cross-sectional online survey

Affiliations

Why 'one size fits all' is not enough when designing COVID-19 immunity certificates for domestic use: a UK-wide cross-sectional online survey

Corina Elena Niculaescu et al. BMJ Open. .

Abstract

Objectives: The present study explored public's willingness to use COVID-19 immunity certificates across six different domestic scenarios.

Design: Cross-sectional online survey.

Setting: UK representative survey conducted on 3 August 2021.

Participants: 534 UK residents over 18 years old.

Interventions: Participants replied to the same set of questions.

Primary and secondary outcome measures: The primary outcome measure was willingness to use immunity certificates across three different domestic settings: (1) visiting the general practitioner (GP) for a non-urgent health issue; (2) dining in a restaurant and (3) attending a performance in a theatre. For each setting two options, one prioritising convenience (option A) and the other privacy (option B), were offered. Our secondary outcome measures were computed indices from items adapted from the Health Belief Model; attitudes towards sharing immunity status with service providers; prior to COVID-19 lifestyle. In addition, we recorded data about respondents' sociodemographic characteristics.

Results: Respondents were more willing to use immunity certificates that prioritised convenience (92%), rather than privacy (76%), when visiting their GP . However, privacy was more favourable in the other two settings (dining in a restaurant (84%) and going to a theatre (83%)) compared with convenience (38% and 39% respectively). Personal beliefs about COVID-19 and immunity certificates were associated with variations in willingness to use these across all scenarios. No variations were observed across sociodemographics and lifestyle.

Conclusions: The findings of this survey suggest that there is not one-size-fits-all solution for designing immunity certificates. Immunity certificates are complex sociotechnical systems, any attempt to implement these for domestic use should be tailored to different settings and user needs. The design of certification services requires a more evidence-based approach and further research is needed to understand how different settings, design elements (like convenience or privacy) and personal beliefs about the pandemic should inform their design.

Keywords: COVID-19; health informatics; public health.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Description of the six scenarios (the number represents one of the three settings while the letter the design option, convenience or privacy). GP, general practitioner; NHS, National Health Service.
Figure 2
Figure 2
Distribution of number of responses (N) across settings (visiting the general practitioner (GP), dining in a restaurant, attending a performance in the theatre) and design options (convenience/privacy).
Figure 3
Figure 3
(A) Index of certificate severity (perceived severity of not using immunity certificates) and (B) index of COVID-19 susceptibility across settings and design options (convenience/privacy).
Figure 4
Figure 4
Willingness to share immunity status with service providers (theatre/cinema/gallery) by across settings and design options (convenience/privacy).

References

    1. Wilf-Miron R, Myers V, Saban M. Incentivizing Vaccination Uptake: The "Green Pass" Proposal in Israel. JAMA 2021;325:1503-1504. 10.1001/jama.2021.4300 - DOI - PubMed
    1. Larremore DB, Bubar KM, Grad YH. Implications of Test Characteristics and Population Seroprevalence on "Immune Passport" Strategies. Clin Infect Dis 2021;72:e412–4. 10.1093/cid/ciaa1019 - DOI - PMC - PubMed
    1. Liew CH, Flaherty GT. Immunity passports to travel during the COVID-19 pandemic: controversies and public health risks. J Public Health 2021;43:e135–6. 10.1093/pubmed/fdaa125 - DOI - PMC - PubMed
    1. Voo TC, Reis AA, Thomé B, et al. . Immunity certification for COVID-19: ethical considerations. Bull World Health Organ 2021;99:155–61. 10.2471/BLT.20.280701 - DOI - PMC - PubMed
    1. Liz J. COVID-19, immunoprivilege and structural inequalities. Hist Philos Life Sci 2021;43:1–6. 10.1007/s40656-020-00356-5 - DOI - PMC - PubMed

Publication types